Treatment of antibody-mediated rejection with high-dose immunoglobulins in ABO-incompatible liver transplant recipient

Transplant International

Volumn 20, Issue 5, 2007, Pages 467-470

  Urbani, Lucio ^a   Mazzoni, Alessandro ^a   Simone, Paolo De ^a   Catalano, Gabriele ^a   Coletti, Laura ^a   Montin, Umberto ^a   Morelli, Luca ^a   Campani, Daniela ^a   Pollina, Luca ^a   Biancofiore, Gianni ^a   Bindi, Lucia ^a   Scatena, Fabrizio ^a   Filipponi, Franco ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

ABO incompatible liver transplantation; Antibody mediated rejection; Immunoglobulins; Photopheresis; Xenotransplantation

Indexed keywords

ALANINE AMINOTRANSFERASE; HEMAGGLUTININ; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; INTERLEUKIN 2 RECEPTOR ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PSORALEN; STEROID; TACROLIMUS;

ABSENCE OF SIDE EFFECTS; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILIARY TRACT DISEASE; BLOOD GROUP A; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP O; CASE REPORT; CAUSE OF DEATH; CLINICAL FEATURE; COMPLEMENT DEPENDENT CYTOTOXICITY; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG WITHDRAWAL; EMERGENCY SURGERY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; GRAFT INFECTION; GRAFT RECIPIENT; GRAM NEGATIVE SEPSIS; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER FUNCTION TEST; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER HISTOLOGY; LIVER RESECTION; MALE; MULTIPLE ORGAN FAILURE; PLASMAPHERESIS; PRIORITY JOURNAL; PUVA; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ABO BLOOD-GROUP SYSTEM; AGED; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FATAL OUTCOME; GRAFT REJECTION; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PLASMAPHERESIS;

EID: 34047229119     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2006.00447.x     Document Type: Article

References (8)

1. Gugenheim J, Samuel D, Reynes M, Bismuth H. Liver transplantation across ABO blood group barriers. Lancet 1990; 336: 519.
2. Hanto DW, Fecteau AH, Alonso MH, Valente JF, Whiting JF. ABO-incompatible liver transplantation with no immunological graft losses using total plasma exchange, splenectomy, and quadruple immunosuppression: evidence for accommodation. Liver Transpl 2003; 9: 22.
3. Kozaki K, Egawa H, Kasahara M et al. Therapeutic strategy and the role of apheresis therapy for ABO incompatible living donor liver transplantation. Ther Apher Dial 2005; 9: 285.
4. Kazatchkine MD, Kaveri SV. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 2001; 345: 747.
5. Morioka D, Sekido H, Kubota K et al. Antibody-mediated rejection after adult ABO-incompatible liver transplantation remedied by gamma-globulin bolus infusion combined with plasmapheresis. Transplantation 2004; 78: 1225.
6. Urbani L, Fabre M, Cardoso J et al. Predominant role of the Fab fragment in delaying hyperacute rejection in guinea pig-to-rat xenotransplantation. Transplantation 1998; 66: 395.
7. Xupeng GE, Uzunel M, Ericzon BG, Sumitran-Holgersson S. Biliary epithelial cell antibodies induce expression of toll-like receptors 2 and 3: a mechanism for post-liver transplantation cholangitis? Liver Transpl 2005; 11: 911.
8. Urbani L, Mazzoni A, Catalano G et al. The use of extracorporeal photopheresis for allograft rejection in liver transplant recipients. Transplant Proc 2004; 36: 3068.